After-hours movers: Geron lower on offering, Inter Parfums gains on raised guidance

This post was originally published on this site

https://i-invdn-com.investing.com/news/LYNXMPED2T082_M.jpg

Vyant Bio Inc (NASDAQ:VYNT) 118% HIGHER; engaged LifeSci Capital as its financial advisor to assist in exploring a range of strategic alternatives focused on enhancing shareholder value.

Geron Corporation (NASDAQ:GERN) 11% LOWER; intends to offer and sell $175 million of shares of its common stock in an underwritten public offering. Shares rose 33% intra-day on positive drug data.

Personalis, Inc. (NASDAQ:PSNL) 10% HIGHER; estimates revenue of approximately $16.7M for the fourth quarter of 2022 and approximately $65.0M for the full year of 2022, which exceeds the company’s previous full year guidance range of $63.0 to $64.0M. (Consensus sees Q4 revenue of $15.3M).

Richardson Electronics Ltd (NASDAQ:RELL7% HIGHER; reported Q2 EPS of $0.39, $0.10 better than the analyst estimate of $0.29. Revenue for the quarter came in at $65.9M versus the consensus estimate of $64.5M.

Inter Parfums, Inc. (NASDAQ:IPAR) 5% HIGHER; announced that it is raising its guidance for year ended December 31, 2022, in light of better-than-expected fourth quarter sales. The Company is now expecting full-year 2022 net sales of $1.08 billion; previous sales guidance was $1.025B. With the increase in sales and concurrent operating leverage, diluted earnings per share should approximate $3.60, up from $3.40, the prior estimate. Thus, management is looking for a 23% increase in net sales and a 31% increase in diluted earnings per share as compared to 2021. Inter Parfums plans to announce final 2022 sales on or about January 23, 2023 and full year results on or about February 28, 2023.

Simulations Plus (NASDAQ:SLP) 3% LOWER; reported Q1 EPS of $0.06, $0.03 worse than the analyst estimate of $0.09. Revenue for the quarter came in at $11.96M versus the consensus estimate of $12.39M. Simulations Plus sees FY2023 EPS of $0.63-$0.67, versus the consensus of $0.64. Simulations Plus sees FY2023 revenue of $59.3-62M, versus the consensus of $61.27M

T-Mobile US, Inc. (NASDAQ:TMUS) 2% HIGHER; announced postpaid net customer additions of 6.4M, best in industry and record high, above high end of guidance.